Abstract
Thapsigargin is a specific inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase of the endoplasmic reticulum. Here, we show that stimulation of human HaCaT keratinocytes with nanomolar concentrations of thapsigargin triggers expression of activating transcription factor (ATF) 3, a basic-region leucin zipper transcription factor. ATF3 expression was also up-regulated in thapsigargin-stimulated glioma cells, hepatoma cells, retinal pigment epithelial cells, and airway epithelial cells. Thapsigargin-induced up-regulation of ATF3 expression in keratinocytes was attenuated by BAPTA-acetoxymethyl ester or by expression of the Ca2+-binding protein parvalbumin in the cytosol of HaCaT cells but not by a panel of pharmacological agents that chelate extracellular Ca2+ (EGTA) or inhibit either ryanodine receptors (dantrolene) or voltage-gated Ca2+ channels (nifedipine). Hence, elevated levels of intracellular Ca2+, released from intracellular stores, are essential for the effect of thapsigargin on the biosynthesis of ATF3. The thapsigargin-induced signaling pathway was blocked by expression of either mitogen-activated protein kinase phosphatase-1 or -5. Experiments involving pharmacological and genetic tools revealed the importance of c-Jun N-terminal protein kinase (JNK) within the signaling cascade, whereas inhibition of extracellular signal-regulated protein kinase or p38 protein kinase did not attenuate thapsigargin-induced expression of ATF3. Functional studies showed that treatment of HaCaT keratinocytes with thapsigargin led to a 2-fold induction of caspase-3/7 activity. The up-regulation of caspase-3/7 activity in thapsigargin-stimulated HaCaT cells was attenuated by inhibition of JNK. Together, these data show that stimulation of HaCaT cells with thapsigargin induces a specific signaling pathway in keratinocytes involving activation of JNK, biosynthesis of ATF3, and up-regulation of caspase-3/7 activity.
Footnotes
↵
The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
This work was supported by the Deutsche Forschungsgemeinschaft (DFG) [Grants SFB530/C14, SFB530A3].
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.110.067637.
-
ABBREVIATIONS:
- ATF
- activating transcription factor
- HaCaT
- human adult low calcium temperature keratinocyte
- [Ca2+]i
- intracellular Ca2+ concentration
- JNK
- c-Jun N-terminal protein kinase
- MAP
- mitogen-activated protein
- MKP
- mitogen-activated protein kinase phosphatase
- DMSO
- dimethyl sulfoxide
- PD98059
- 2′-amino-3′-methoxyflavone
- SB203580
- 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole
- SP600125
- 1,9-pyrazoloanthrone
- BAPTA
- 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid
- AM
- acetoxymethyl ester
- 4OHT
- 4-hydroxytamoxifen
- MEK
- mitogen-activated/extracellular signal responsive kinase kinase
- TUNEL
- terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labeling
- 7-AAD
- 7-amino-actinomycin D
- NES
- nuclear export signal
- ERK
- extracellular-signal regulated protein kinase
- MEKK1
- MEK kinase-1
- SEK
- stress-activated protein kinase/ERK kinase
- MKK6
- MAP kinase kinase 6
- Egr-1
- early growth response 1
- HDAC1
- histone deacetylase 1.
- Received July 19, 2010.
- Accepted August 16, 2010.
- Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|